XPH vs IDNA

AXPH

BIDNA

Measures won3–3level · of 6 · 5Y

$10,000 · 5Y$13,951XPH · IDNA $8,497

Lowest cost0.35%XPH · $35 on $10k

Most income0.69%IDNA · $69 on $10k

Smallest drop−10.6%IDNA · worst fall in 1Y

Held in common2.9%XPH and IDNA

State Street SPDR S&P Pharmaceuticals ETF · $530MiShares Genomics Immunology and Healthcare ETF · $340M

+23.4%3 years · per year$18,773 · $21,631+29.3%

+6.9%5 years · per year$13,951 · $8,497−3.2%

0.35%Expense ratio$35 · $47 on $10k · lower wins0.47%

0.41%12-mo yield$41 · $69 on $10k0.69%

End-of-day Nov 12, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two

5Y2 funds

#			Trend
1	AXPH	State Street SPDR S&P Pharmaceuticals ETFRead Desk		0.35%	0.41%	−2.6%	+20.0%	+31.9%	+23.4%	+6.9%	−16.5%	$530M
2	BIDNA	iShares Genomics Immunology and Healthcare ETFRead Desk		0.47%	0.69%	−3.2%	+56.7%	+58.3%	+29.3%	−3.2%	−10.6%	$340M

End-of-day Nov 12, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

5Y2 funds

#			Trend
1	AXPH	State Street SPDR S&P Pharmaceuticals ETFRead Desk		0.35%	0.41%	−2.6%	+20.0%	+31.9%	+23.4%	+6.9%	−16.5%	$530M
2	BIDNA	iShares Genomics Immunology and Healthcare ETFRead Desk		0.47%	0.69%	−3.2%	+56.7%	+58.3%	+29.3%	−3.2%	−10.6%	$340M

End-of-day Nov 12, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

Cards for this view

XPH

SPDR S&P Pharmaceuticals

$13,951

IDNA

iShares Genomics Immunology and Healthcare

$8,497

Loading…